NuPathe Submits Zelrix NDA for the Treatment of Migraine
Safeguard Scientifics’ partner company NuPathe submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA). The NDA was filed for ZelrixTM,…
Posted by
Safeguard Insights
Partner Company Clarient (Nasdaq: CLRT) to be Acquired by GE Healthcare for $587 Million
At Safeguard Scientifics, our strategy is to provide growth capital for entrepreneurial and innovative life sciences and technology companies, build value in those companies and…
Posted by
AdvantEdge Healthcare Solutions, Bridgevine, and Portico Systems named to Inc. 5000 List
Inc. recently issued its prestigious list of America’s fastest growing private companies (Inc. 5000) and we are proud to announce that three of our partner…
Posted by
Swap Movement Comes of Age
First there was e-commerce, then online auctions, and then online classifieds for buying and selling used items. Now there’s an increasing demand for online trading,…
Posted by
Bloomberg Businessweek says Avid likely to Beat GE, Bayer to Market
On the eve of the International Conference on Alzheimer’s Disease (ICAD), Bloomberg Businessweek’s Elizabeth Lopatto and Kanoko Matsuyama reported that Avid Radiopharmaceuticals, Inc., a Safeguard…
Posted by
The Next Frontier: Opportunities in Regenerative Medicine
While there are a wealth of opportunities to deploy capital in a variety of life sciences companies, the evolution and potential long-term impact of regenerative…
Posted by
New York Times puts Avid’s Technology Front and Center
Avid Radiopharmaceuticals was featured on the front page of The New York Times today. The article, “Promise Seen for Detection of Alzheimer’s,” by Gina Kolata (@ginakolata), highlights…
Posted by
Fox Business Feature on Swaptree
Jeff Bennett, newly appointed CEO at Safeguard Scientifics’ technology partner company Swaptree, was recently featured on FOX Business to talk about the “swap movement.” Jeff…
Posted by
Diagnostic Imaging Continues to Garner Investor Interest
On the heels of the BIO International Convention, I came across this piece by FierceBiotech’s Maureen Martino highlighting a panel of biotech VCs who made…
Posted by
